Ones To Watch News
Refine Search
Biotechnology
Epitopea, a UK and Canada-based cancer immunotherapeutics company, has partnered with nucleic acid delivery specialist Genevant Sciences to develop new RNA-based therapies targeting proprietary tumor antigens. 20 December 2024
Pharmaceutical
US biotech Assembly Biosciences has announced an equity investment of $20.1 million by Gilead Sciences to purchase additional common stock in the company and an amendment to their collaboration to advance the research and development of novel antiviral therapies with $10 million in accelerated funding. 20 December 2024
Pharmaceutical
Privately-held Xcovery Holdings, an oncology-focused pharma company, has announced that the US Food and Drug Administration (FDA) has approved Ensacove (ensartinib) for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer (NSCLC). 19 December 2024
Biotechnology
Privately-held biotech Ottimo Pharma today announces the completion of a Series A financing round of over $140 million. 19 December 2024
Biotechnology
Safi Biotherapeutics, a specialist in stem-cell derived red blood cell products, has received Rare Pediatric Disease designation and Orphan Drug designation from the US regulator. 19 December 2024
Biotechnology
BioAge Labs today announced a multi-year research collaboration with Swiss pharma giant Novartis, with the news pushing the US biotech’s shares up 6.1% to $4.35 by early afternoon. 18 December 2024
Pharmaceutical
Marking its second deal this month alone, Novo Nordisk has entered into a multi-year collaboration with Massachusetts, USA-based Photys Therapeutics to develop novel proximity-based therapeutics for a cardiometabolic disease target. 18 December 2024
Biotechnology
Cara Therapeutics and Tvardi Therapeutics have announced a definitive agreement to merge, creating a new entity under the Tvardi name. 18 December 2024
Pharmaceutical
SiteOne Therapeutics has announced the completion of a $100 million series C financing, led by Novo Holdings, with participation from OrbiMed, Wellington Management, Mission BioCapital, and others. 18 December 2024
Biotechnology
Flagship Pioneering-founded genome engineering biotech Tessera Therapeutics today announced an investment of up to $50 million from the Bill & Melinda Gates Foundation to develop curative, globally accessible in vivo genetic therapies for sickle cell disease. 18 December 2024
Biotechnology
San Francisco-based Indapta Therapeutics, a privately held start-up developing next-generation cell therapies, has raised $22.5 million in a new financing round. The firm raised over $50 million in series A funding in 2022. 18 December 2024
Biotechnology
French CNS specialist Theranexus saw its shares leap more than 34% to 0.65 euros as it revealed a license and supply agreement with Exeltis to commercialize TX01, its novel formulation of a compound already approved in the indication for the treatment of rare neurological diseases. 18 December 2024
Biotechnology
Shares in US biopharma Viridian Therapeutics shot up by 21% on Monday. 17 December 2024
Biotechnology
US antivirals giant Gilead Sciences today revealed it has entered into a strategic collaboration to discover and develop novel, small molecule therapies across multiple targets with Californian biotech Terray Therapeutics. 17 December 2024
Pharmaceutical
Swedish biotech company Inify Laboratories has raised approximately 135 million kroner ($12.3 million) through a private placement, supporting a planned expansion into the UK. 16 December 2024
Biotechnology
Dewpoint Therapeutics and ConcertAI have announced the first phase of their translational oncology partnership, aligned around the former company's latest drug candidate, DPTX3186. 16 December 2024
Biotechnology
Bicycle Therapeutics, a UK-headquartered pharma company developing a new class of therapeutics based on its proprietary bicyclic peptide technology, closed a third lower on Friday. 16 December 2024
Biotechnology
In a filing with the US financial regulator, German mRNA specialist BioNTech has noted the lifting of a partial clinical hold on its PRESERVE-003 trial. 16 December 2024
Biotechnology
VectorY Therapeutics, a Netherlands-based biotech focused on neurodegenerative diseases, has appointed Jim Scibetta as chief executive officer. 16 December 2024
Biotechnology
Sino-American biotech BeiGene has announced it has entered into a global licensing agreement with China’s CSPC Zhongqi Pharmaceutical Technology for SYH2039, a novel methionine adenosyltransferase 2A (MAT2A)-inhibitor being explored for solid tumors. 13 December 2024
Pharmaceutical
Denmark-based Bavarian Nordic’s shares were up 11.9% at 312.20 Danish kroner by mid-afternoon, as it announced today that the company has entered a funding agreement with the Danish Ministry of Health to further advance the development of ABNCoV2, Bavarian’s COVID-19 vaccine candidate. 23 August 2021
Pharmaceutical
Texas, USA-based Lexicon Pharmaceuticals today presented additional analyses of sotagliflozin data from the SOLOIST and SCORED Phase III clinical trials at ESC Congress 2021 - The Digital Experience. 23 August 2021
Biotechnology
US privately-held biotech HiberCell today announced the acquisition of Genuity Science, a life science technology company – previously known as WuXi NextCODE and with Chinese backing - that provides world-leading genomics and multi-omic analytics bolstered by an advanced artificial intelligence (AI) and machine learning (ML) platform to illuminate the underlying cause of cancer and other diseases. 17 August 2021
Biotechnology
Shares in British biotech Tiziana Life Sciences rose nearly 4% on Tuesday morning, after the firm announced positive results for its nasally-administered COVID-19 therapy foralumab. 17 August 2021
Pharmaceutical
Physics-based US software specialist Schrödinger and China’s Zai Lab Limited have entered into a global discovery, development and commercialization collaboration focused on a novel program in oncology targeting DNA damage response. 16 August 2021
Biotechnology
Mustang Bio, a cell & gene therapy specialist based in Massachusetts, USA, has executed an exclusive license agreement with the prestigious Mayo Clinic, related to its CAR-T cell technology. 13 August 2021
Pharmaceutical
Central nervous system (CNS) specialist Axsome Therapeutics will hope a positive report from GlobalData could take the sting out of a recent run of bad news. 12 August 2021
Biotechnology
German CNS specialist atai Life Sciences has announced the launch of Revixia Life Sciences, a wholly-owned subsidiary developing Salvinorin A (SalA) to treat a variety of mental health disorders. 12 August 2021
Biotechnology
East Coast, USA-based Finch Therapeutics, a specialist in oral biologics, has deepened its partnership with Takeda Pharmaceutical. 11 August 2021
Biotechnology
Yet another public listing via special purpose acquisition company (SPAC) demonstrates the growing popularity of the approach, as an alternative to the traditional initial public offering. 11 August 2021
Biotechnology
German biotech BioNTech saw its shares close up 15% at $447.23 on Monday, after it provided an update on its corporate progress and reported financial results for the second quarter ended June 30, 2021. 10 August 2021
Biotechnology
Shares of Canada’s Liminal BioSciences shot up nearly 28% to $3.65 by close of trading on Monday, after it announced that, its subsidiary Prometic Biotherapeutics (PBT) has entered into a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for $105 million. 10 August 2021
Biotechnology
US biotech bluebird bio yesterday reported financial results and business highlights for the second quarter ended June 30, 2021, which failed to impress investors, so the stock tumbled 27.5% to $18.16 by close of trading. 10 August 2021
Biotechnology
Swiss clinical-stage biotech MoonLake Immunotherapeutics today announced the appointment of Simon Sturge as chairman. 10 August 2021
Biotechnology
UK-based drug discovery and development company Mission Therapeutics and US pharma major AbbVie today announced progression of selected deubiquitylating enzyme (DUB) targets into the next phase of research in their neurodegenerative disease collaboration. 9 August 2021
Biotechnology
Shares of Sino-American biotech BeyondSpring leapt 176% by the close of trading, after rising as much as 211% earlier in the day, after the company announced positive top-line data of DUBLIN-3 registrational trial in plinabulin in combination with docetaxel to treat 2nd and 3rd line non-small cell lung cancer (NSCLC) (EGFR wild type) compared to docetaxel alone (n=559). 7 August 2021
Biotechnology
Japanese drug major Ono Pharmaceutical has entered into a research collaboration agreement with Cambridge, UK-based Healx Limited, an artificial intelligence (AI)-driven biopharmaceutical company, on Healx’ unique AI technology to jointly discover and develop novel, efficacious treatment drugs for diseases with unmet medical needs. 6 August 2021
Biotechnology
Making another move to improve its pharma portfolio, Germany’s Bayer today announced the acquisition of US biotech start-up Vividion Therapeutics. 5 August 2021
Biotechnology
Shares of New Jersey, USA-based Outlook Therapeutics leapt nearly 27% to $2.87 pre-market yesterday after it announced positive clinical and highly statistically-significant top-line results from its pivotal Phase III NORSE TWO safety and efficacy trial evaluating ONS-5010/Lytenava (bevacizumab) for treatment of neovascular age-related macular degeneration (wet AMD). 4 August 2021
Biotechnology
Japanese drugmaker Kyowa Kirin and new Synaffix today announced the signing of a license and option agreement, marking the second deal for the Dutch biotech in less than a month. 4 August 2021
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze